Heart failure with preserved ejection fraction—a concise review

DM Adamczak, MT Oduah, T Kiebalo… - Current cardiology …, 2020 - Springer
Abstract Purpose of Review Heart failure with preserved ejection fraction (HFpEF) is a
relatively new disease entity used in medical terminology; however, both the number of …

Transthyretin cardiac amyloidosis

AK Mankad, KB Shah - Current cardiology reports, 2017 - Springer
Abstract Purpose of Review Transthyretin (TTR)-related cardiac amyloidosis is a progressive
infiltrative cardiomyopathy that mimics hypertensive, hypertrophic heart disease and may go …

Амилоидоз сердца: взгляд терапевта и кардиолога

ЕВ Резник, ТЛ Нгуен, ЕА Степанова… - Архивъ внутренней …, 2020 - cyberleninka.ru
Амилоидоз сердца (амилоидная кардиомиопатия)-поражение сердца, обусловленное
внеклеточным отложением амилоида. В ряде случаев может быть локальное …

[HTML][HTML] Phenotyping in heart failure with preserved ejection fraction: A key to find effective treatment

MM Zawadzka, M Grabowski… - Advances in Clinical …, 2022 - advances.umw.edu.pl
Heart failure with preserved ejection fraction (HFpEF) is an increasingly widespread medical
condition, with excessive morbidity and mortality. Recently, for the first time in HFpEF, a …

Real-life evaluation of an algorithm for the diagnosis of cardiac amyloidosis

M Bézard, M Kharoubi, A Galat, F Le Bras… - Mayo Clinic …, 2023 - Elsevier
Objective To evaluate the real-life use of a modified Gillmore algorithm with a" one-stop-
shop” approach, bone scintigraphy (BS), a monoclonal gammopathy test (GT), a salivary …

Cardiac amyloidosis: Internist and cardiologist insight

EV Reznik, TL Nguyen, EA Stepanova… - The Russian Archives …, 2020 - medarhive.ru
Cardiac amyloidosis (amyloid cardiomyopathy) is a disease damage to the heart caused by
extracellular amyloid deposition. In some cases, there may be local damage to the structures …

[HTML][HTML] Genomic screening identifies individuals at high risk for hereditary transthyretin amyloidosis

ER Soper, SA Suckiel, GT Braganza… - Journal of Personalized …, 2021 - mdpi.com
The TTR V142I variant associated with hereditary transthyretin amyloidosis (hATTR) is
present in up to 4% of African American (AA) and 1% of Hispanic/Latinx (HL) individuals and …

Clinical translation of genetic testing in TTR amyloidosis: genotype-phenotype correlations, management of asymptomatic carriers and familial screening

R Scirpa, D Russo, G Tini, M Sclafani, A Tropea… - Vessel Plus, 2022 - iris.uniroma1.it
Abstract Transthyretin (TTR)-related amyloidosis (ATTR) is a heterogeneous disease with
different organ involvement depending on the type of TTR infiltration [mutated (vTTR) or wild …

Oxidative damage in immunoglobulin light chain and transthyretin cardiac amyloidosis–a closer look

E Cavallone, AH Mousavi, C Biolé… - Redox …, 2024 - rem.bioscientifica.com
Heart failure is a progressive disease, representing a growing cause of morbidity,
hospitalization, and mortality. An increasingly common type of heart failure with preserved …

Plasma Transthyretin and Its Ligands

M Franzini, C Sanguinetti, V Musetti… - Cardiac Amyloidosis …, 2024 - Springer
Transthyretin (TTR) is a homotetrameric protein mainly synthesized by the liver and the
choroid plexus whose function is to carry the thyroid hormone thyroxine (t4) and the …